Company Filing History:
Years Active: 2004-2005
Title: Edward Vacek: Innovator in Pain Treatment
Introduction
Edward Vacek is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for pain treatment. With a total of 3 patents, Vacek's work has the potential to impact many lives.
Latest Patents
Vacek's latest patents include innovative compounds such as 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain. One of the key aspects of his work involves a compound, 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione. This compound, along with its enantiomers and pharmaceutically-acceptable salts, is designed to provide effective pain relief. The examiner's statement of reasons for allowance highlights the importance of limiting certain groups in the claims, which has allowed for the advancement of his patent applications.
Career Highlights
Vacek is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on developing innovative solutions for pain management. His contributions to the field have been recognized through his patents, which reflect his commitment to improving patient care.
Collaborations
Some of Vacek's notable coworkers include Dean Brown and Rebecca Urbanek. Their collaborative efforts have likely contributed to the success of his projects and the advancement of their shared goals in pharmaceutical innovation.
Conclusion
Edward Vacek's work in the pharmaceutical industry exemplifies the impact of innovation on pain treatment. His patents and collaborations highlight his dedication to improving healthcare solutions.